DBV Technologies (DBV.PA) shares rise 3.4% on FDA BLA filing for Viaskin Peanut patch ages 4-7
DBV submitted a biologics license application to the FDA for its Viaskin Peanut patch for children aged four to seven. Portzamparc said the milestone follows a failed 2020 application for the 4-11 age group and that the redesigned patch and stronger clinical data support the new submission; DBV requested priority revie